BIM
KERX

BlackRock Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

BlackRock Investment Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.73M Sell
294,398
-908
-0.3% -$4.96K ﹤0.01% 2325
2016
Q3 		$1.57M Sell
295,306
-770
-0.3% -$4.15K ﹤0.01% 2357
2016
Q2 		$1.96M Sell
296,076
-53,802
-15% -$301K ﹤0.01% 2120
2016
Q1 		$1.63M Buy
349,878
+5,406
+2% +$21.6K ﹤0.01% 2137
2015
Q4 		$1.74M Buy
344,472
+575
+0.2% +$2.73K ﹤0.01% 2183
2015
Q3 		$1.21M Sell
343,897
-5,668
-2% -$38K ﹤0.01% 2460
2015
Q2 		$3.49M Buy
349,565
+69,957
+25% +$750K ﹤0.01% 1779
2015
Q1 		$3.56M Buy
279,608
+30,794
+12% +$396K ﹤0.01% 1632
2014
Q4 		$3.52M Sell
248,814
-1,441
-0.6% -$22.3K ﹤0.01% 1633
2014
Q3 		$3.44M Buy
250,255
+125
+0% +$1.91K ﹤0.01% 1610
2014
Q2 		$3.85M Buy
250,130
+4,001
+2% +$56.7K 0.01% 1585
2014
Q1 		$4.19M Buy
246,129
+21,520
+10% +$325K 0.01% 1497
2013
Q4 		$2.91M Sell
224,609
-6,163
-3% -$73.6K ﹤0.01% 1746
2013
Q3 		$2.33M Buy
230,772
+12,419
+6% +$111K ﹤0.01% 1851
2013
Q2 		$1.63M Buy
+218,353
New +$1.71M ﹤0.01% 2013

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Investment Management's KERX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Keryx Biopharmaceuticals Inc (KERX) stake by 0.31% in Q4 2016, selling an estimated $4.96K and leaving 294,398 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

BlackRock Investment Management first reported a position in KERX in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.19M in Q1 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q4 2016.

  • BlackRock Investment Management held 294,398 shares of Keryx Biopharmaceuticals Inc worth $1.73M as of Q4 2016.
  • BlackRock Investment Management sold 908 Keryx Biopharmaceuticals Inc shares in Q4 2016, an estimated $4.96K.
  • Keryx Biopharmaceuticals Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2325 holding.
  • BlackRock Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Keryx Biopharmaceuticals Inc position peaked at $4.19M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.